Does RAMIPRIL Cause Product formulation issue? 19 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Product formulation issue have been filed in association with RAMIPRIL (Ramipril). This represents 0.1% of all adverse event reports for RAMIPRIL.
19
Reports of Product formulation issue with RAMIPRIL
0.1%
of all RAMIPRIL reports
0
Deaths
4
Hospitalizations
How Dangerous Is Product formulation issue From RAMIPRIL?
Of the 19 reports, 4 (21.1%) required hospitalization, and 4 (21.1%) were considered life-threatening.
Is Product formulation issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAMIPRIL. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does RAMIPRIL Cause?
Acute kidney injury (3,286)
Dyspnoea (2,537)
Dizziness (2,490)
Hypotension (2,417)
Fatigue (2,415)
Drug ineffective (2,412)
Nausea (2,219)
Vomiting (2,055)
Off label use (2,053)
Hypertension (2,046)
What Other Drugs Cause Product formulation issue?
MINOXIDIL (1,369)
LEVOTHYROXINE (740)
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (174)
OMEPRAZOLE (99)
METHYLPHENIDATE (78)
OXYCODONE (73)
ACETAMINOPHEN\HYDROCODONE (62)
ACETAMINOPHEN\OXYCODONE (61)
ACETAMINOPHEN (59)
BUPROPION (59)
Which RAMIPRIL Alternatives Have Lower Product formulation issue Risk?
RAMIPRIL vs RAMUCIRUMAB
RAMIPRIL vs RANEXA
RAMIPRIL vs RANIBIZUMAB
RAMIPRIL vs RANIMUSTINE
RAMIPRIL vs RANITIDINE